Clofarabine
Generic name: Clofarabine
Brand names: Clolar
Dosage form: intravenous solution (1 mg/mL)
Drug class:
Antimetabolites
Usage of Clofarabine
Clofarabine is used to treat acute lymphoblastic leukemia (a type of blood cancer) in children and young adults up to 21 years old.
Clofarabine is usually given after other treatments have failed.
Clofarabine may also be used for purposes not listed in this medication guide.
Clofarabine side effects
Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).
Seek medical attention right away if you have signs of inflammation in your body: flu-like symptoms, fast heartbeats, sudden swelling or shortness of breath, rapid breathing, or feeling light-headed.
Clofarabine may cause serious side effects. Call your doctor at once if you have:
Common side effects of clofarabine may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Clofarabine
Tell your doctor if you have recently been sick with flu symptoms or diarrhea, or if you have ever had:
You may need to have a negative pregnancy test before starting this treatment.
Clofarabine can harm an unborn baby if the mother or the father is using this medicine.
This medicine may affect fertility (ability to have children) in both men and women. However, it is important to use birth control to prevent pregnancy because clofarabine can harm an unborn baby.
Do not breastfeed while using this medicine, and for at least 2 weeks after your last dose.
Relate drugs
- Adrucil
- Adrucil injection
- Alimta
- Arranon
- Clofarabine
- Clolar
- Cytarabine
- Cytarabine liposome
- Mylocel
- Capecitabine
- Cladribine
- Cladribine (Intravenous)
- Cladribine (Oral)
- Cladribine injection
- Dacogen
- Decitabine
- Depocyt
- Droxia
- Floxuridine
- Fludarabine (Intravenous)
- Fludarabine (Oral)
- Fludarabine injection
- Fluorouracil (Intravenous, Injection)
- Fluorouracil injection
- Folotyn
- FUDR
- Gemcitabine
- Gemzar
- Hydrea
- Hydroxyurea
- Infugem
- Leustatin
- Leustatin injection
- Mavenclad
- Mercaptopurine
- Nelarabine
- Oforta
- Pemetrexed
- Pemfexy
- Pralatrexate
- Purinethol
- Siklos
- Tabloid
- Thioguanine
- Xeloda
How to use Clofarabine
Usual Adult Dose for Acute Lymphoblastic Leukemia:
18 to less than 22 years:52 mg/m2 IV over 2 hours daily for 5 consecutive days of a 28-day cycle; repeat every 2 to 6 weeksComments:-Subsequent cycles should begin no sooner than 14 days from day 1 of the previous cycle. -Subsequent cycles may be administered when the ANC is greater than or equal to 750/mm3.-Provide supportive care, such as IV fluids, antihyperuricemics, and alkalinization of urine throughout therapy to reduce the risk of tumor lysis and other adverse events.-Monitor renal, hepatic, and cardiac function during therapy.-Monitor patients taking medications known to affect blood pressure. -Discontinue therapy if hypotension develops during the 5 days of administration.Use: For patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least 2 prior regimens
Usual Pediatric Dose for Acute Lymphoblastic Leukemia:
1 year and older:52 mg/m2 IV over 2 hours daily for 5 consecutive days of a 28-day cycle; repeat every 2 to 6 weeksComments:-Subsequent cycles should begin no sooner than 14 days from day 1 of the previous cycle. -Subsequent cycles may be administered when the ANC is greater than or equal to 750/mm3.-Provide supportive care, such as IV fluids, antihyperuricemics, and alkalinization of urine throughout therapy to reduce the risk of tumor lysis and other adverse events.-Monitor renal, hepatic, and cardiac function during therapy.-Monitor patients taking medications known to affect blood pressure. -Discontinue therapy if hypotension develops during the 5 days of administration.Use: For patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least 2 prior regimens
Warnings
Seek medical attention right away if you have signs of inflammation in your body: fever, fast heartbeats, sudden swelling or shortness of breath, rapid breathing, or feeling light-headed.
clofarabine can cause life-threatening side effects including serious infections, bleeding, or harm to your liver or kidneys.
Call your doctor at once if you have: fever, chills, pale skin, trouble breathing, sudden numbness or weakness, problems with vision or speech, stomach pain or swelling, bruising, decreased urination, rapid weight gain, dark urine, yellowing of your skin or eyes, blood in your urine or stools, or if you cough up blood.
What other drugs will affect Clofarabine
Clofarabine can harm your liver or kidneys, especially if you also use certain medicines for infections, tuberculosis, birth control, hormone replacement, high cholesterol, heart problems, high blood pressure, cancer, osteoporosis, organ transplant rejection, bowel disorders, seizures, pain, or arthritis (including Tylenol, Advil, Motrin, or Aleve).
Other drugs may affect clofarabine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions